Clinical Trial Update: Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating safety and efficacy of topical DLQ01 for androgenetic alopecia in men has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• DLQ01

Snippet

Sponsor: Dermaliq Therapeutics, Inc. | Conditions: Androgenetic Alopecia | Phase 1, Phase 2 | Status: COMPLETED